| |
| |
|
| Insider
Information: |
Sullivan Louis |
| Relationship: |
Director |
| City: |
|
| State: |
|
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
7 |
|
| Direct
Shares |
178,473 |
|
|
Indirect Shares
|
20,185 |
|
|
| Direct
Value |
$9,265,803 |
|
|
|
Indirect Value
|
$1,853,589 |
|
|
| Total
Shares |
198,658 |
|
|
| Total
Value |
$11,119,391 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
4
|
|
Stock
price went up :
|
0
|
2
|
| Stock
price went down : |
0
|
2
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -9.4%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
ANI Pharmaceuticals Inc |
ANIP |
Director |
2011-08-15 |
47,898 |
2003-07-17 |
0 |
Premium* |
|
|
3M Co |
MMM |
Director |
2006-05-09 |
1,722 |
2006-05-09 |
20,185 |
Premium* |
|
|
Bristol-Myers Squibb Co |
BMY |
Director |
2005-04-29 |
8,399 |
2004-04-23 |
0 |
Premium* |
|
|
Equifax Inc |
EFX |
Director |
2004-05-05 |
6,033 |
2004-05-05 |
0 |
Premium* |
|
|
Henry Schein Inc |
HSIC |
Director |
2016-03-04 |
14,096 |
2005-03-18 |
0 |
Premium* |
|
|
United Therapeutics Corp |
UTHR |
|
2023-07-07 |
13,060 |
2007-12-11 |
0 |
Premium* |
|
|
Emergent Biosolutions Inc. |
EBS |
Director |
2023-05-25 |
87,265 |
2010-05-20 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| UTHR |
United Therapeutics Corp |
|
– • – |
2023-07-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
880 |
13,060 |
0 |
- |
|
| EBS |
Emergent Biosolutions Inc... |
Director |
– • – |
2023-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
33,847 |
87,265 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
|
– • – |
2023-03-01 |
4 |
AS |
$245.10 |
$171,570 |
D/D |
(700) |
12,180 |
0 |
% |
|
| UTHR |
United Therapeutics Corp |
|
– • – |
2023-03-01 |
4 |
OE |
$132.30 |
$92,610 |
D/D |
700 |
12,880 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
|
– • – |
2023-02-01 |
4 |
OE |
$132.30 |
$92,610 |
D/D |
700 |
12,880 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
|
– • – |
2023-02-01 |
4 |
AS |
$261.33 |
$182,931 |
D/D |
(700) |
12,180 |
0 |
% |
|
| UTHR |
United Therapeutics Corp |
|
– • – |
2023-01-03 |
4 |
AS |
$276.26 |
$193,382 |
D/D |
(700) |
12,180 |
0 |
% |
|
| UTHR |
United Therapeutics Corp |
|
– • – |
2023-01-03 |
4 |
OE |
$132.30 |
$92,610 |
D/D |
700 |
12,880 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
|
– • – |
2022-12-01 |
4 |
AS |
$279.89 |
$195,923 |
D/D |
(700) |
12,180 |
0 |
% |
|
| UTHR |
United Therapeutics Corp |
|
– • – |
2022-12-01 |
4 |
OE |
$132.30 |
$92,610 |
D/D |
700 |
12,880 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
|
– • – |
2022-11-01 |
4 |
AS |
$230.28 |
$161,196 |
D/D |
(700) |
12,180 |
0 |
% |
|
| UTHR |
United Therapeutics Corp |
|
– • – |
2022-11-01 |
4 |
OE |
$132.30 |
$92,610 |
D/D |
700 |
12,880 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
|
– • – |
2022-10-03 |
4 |
AS |
$211.56 |
$150,208 |
D/D |
(710) |
12,180 |
0 |
% |
|
| UTHR |
United Therapeutics Corp |
|
– • – |
2022-10-03 |
4 |
OE |
$132.30 |
$93,933 |
D/D |
710 |
12,890 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
|
– • – |
2022-09-02 |
4 |
S |
$225.98 |
$1,109,550 |
D/D |
(4,910) |
12,180 |
0 |
% |
|
| UTHR |
United Therapeutics Corp |
|
– • – |
2022-09-02 |
4 |
OE |
$101.80 |
$499,838 |
D/D |
4,910 |
17,090 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
|
– • – |
2022-07-08 |
4/A |
OE |
$0.00 |
$0 |
D/D |
1,080 |
12,180 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
|
– • – |
2022-07-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,230 |
14,330 |
0 |
- |
|
| EBS |
Emergent Biosolutions Inc... |
Director |
– • – |
2022-05-26 |
4 |
A |
$0.00 |
$0 |
D/D |
8,446 |
53,418 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
|
– • – |
2022-05-26 |
4 |
S |
$223.37 |
$1,419,781 |
D/D |
(6,310) |
11,100 |
0 |
% |
|
| UTHR |
United Therapeutics Corp |
|
– • – |
2022-05-26 |
4 |
OE |
$76.36 |
$481,832 |
D/D |
6,310 |
17,410 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
Director |
• • – |
2021-06-26 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,680 |
11,100 |
0 |
- |
|
| EBS |
Emergent Biosolutions Inc... |
Director |
– • – |
2021-05-20 |
4 |
A |
$0.00 |
$0 |
D/D |
5,027 |
44,972 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
Director |
• • – |
2021-05-11 |
4 |
D |
$194.30 |
$5,829,000 |
D/D |
(30,000) |
9,420 |
0 |
- |
|
| UTHR |
United Therapeutics Corp |
Director |
• • – |
2021-05-11 |
4 |
OE |
$63.90 |
$2,278,950 |
D/D |
30,000 |
24,420 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
